Ladenburg Thalmann Financial Services Inc. | TalkMarkets | Page 1
No data available
No data available

People who follow this stock (32)

Latest Posts

About This Stock More About This Stock
Preferred Vs Common: The Pros & Cons Of Each
Article By: Norman Roberts
Thursday, December 26, 2019 4:07 PM EDT
Preferred shareholders, for the most part, invest with an eye toward a continuing stream of fixed income, not necessarily preferred price appreciation.
In this article: CDMO Also: AHT, CMRE, GSL, NM, NS, SB, SSW, TNP, TOO, TWO, LTS, NYMT, DCP
Read
5 Breakout Stocks For Amazing Returns
Article By: Swarup Gupta
Tuesday, April 16, 2019 1:00 PM EDT
Possibly the single most popular method utilized by active investors is to identify breakout stocks. This method seeks out stocks whose prices are varying within a tight range.
In this article: EXFO, GLDD, CLAR, URG, LTS
Read
January Effect Seems Likely: Buy Small-Cap ETFs & Stocks
Article By: Sweta Killa
Thursday, January 10, 2019 3:31 AM EDT
After a bumpy ride in 2018 and a long list of woes, investors are concerned that the historical trend of “January Effect” will come into play this year.
In this article: LTS, PRTS, VTWG, VTWO, VTWV, JAKK, INTT, IWO, SPSM, NMM
Read
Stock Market Bottom? - Tuesday, October 30, 2018
Video By: Robert Desmond
Tuesday, October 30, 2018 8:54 AM EDT
The US Dollar continues to rally which will pressure the price of gold, oil and silver.
In this video: BCH-X, LTS, INFI, QQQ, DIA, GLD, SPY, USO, UUP, SPX, CERC, SLV
Watch
Cellectar Biosciences Announces Pricing Of $8,000,000 Public Offering
Article By: NASDAQ GlobeNewswire
Wednesday, November 23, 2016 5:14 PM EDT
Cellectar Biosciences, Inc., today announces the pricing of an underwritten public offering of shares of its common stock.
In this article: CLRB Also: LTS
Read

Latest Tweets for $LTS

No tweets yet!

PARTNER HEADLINES